ARCHIVES

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Henschke Responds To Questions from The New York Times

April 29, 2011

ONS, ASCO, AACR Growth Surge Continues; Flex Political Muscles During DC Meetings

June 8, 1990

In Brief: Benacerraf, Snell, Dausset Win Nobel Prize; AACE Seeks Increase In Clinical Education Funds

October 17, 1980

Decision Network Votes 14-11 for Laetrile Testing

September 29, 1978

Flat Centers Budget Irks House Subcommittee; Porter Repeats Call For Funding Bypass Budget

March 23, 1990

Funding Opportunity: Stand Up To Cancer Canada to Fund Two Dream Teams

October 17, 2014